An investor asked on the investor interaction platform: how is the research and development progress of covid-19 rapid detection box of the company? What is the progress of covid-19 rapid detection business in Europe and America? Any plans?
Guangdong Hybribio Biotech Co.Ltd(300639) (300639. SZ) said on the investor interaction platform on January 7 that the company has approved the covid-19 nucleic acid rapid detection box. Please pay attention to the company’s announcement on the progress of this matter.
(source: Daily Economic News)
